Skip to main content
JAMA Network logoLink to JAMA Network
. 2021 May 3;181(7):1021. doi: 10.1001/jamainternmed.2021.2155

Errors in Group Information Supplement

PMCID: PMC8094027  PMID: 33938905

In the article titled “Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial,”1 published online on October 20, 2020, there were errors in the group information Supplement. There were 2 names misspelled in the Supplement. Samy Figueiredo has been corrected from the previous spelling of Samy Figuereido, and Marie-Aude Penet has been corrected from the previous Marie-Aude Pennet. This article Supplement was corrected online.

Reference

  • 1.Hermine O, Mariette X, Tharaux P-L, Resche-Rigon M, Porcher R, Ravaud P; CORIMUNO-19 Collaborative Group . Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):32-40. doi: 10.1001/jamainternmed.2020.6820 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Internal Medicine are provided here courtesy of American Medical Association

RESOURCES